Strand Partners on Indian Breast Cancer Study | GenomeWeb

NEW YORK (GenomeWeb News) – Strand Life Sciences will work with two institutes on a study in India that aims to identify and validate biomarkers for breast cancer, the Bangalore-based firm said Wednesday.

Strand will partner with the Kidwai Memorial Institute of Oncology and the Indian Institute of Science (IISc) to study more than 300 adult Indian women suffering from breast cancer in an effort to generate molecular signatures that could be used to predict response to various therapies and treatments, metastasis, relapse, and disease-free survival rates.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Cell this week: proteomic consequences of genomic changes in ovarian cancer, Human SRMAtlas, and more.

At Nature, John Wilbanks and Eric Topol call for openness in health data.

Law.com predicts that genomic and genetic testing will become common in toxic tort cases.

A Pew Research Center report finds that most Americans are wary of using technologies like gene editing to enhance human abilities.